fda and compounded glp 1 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Did the FDA Ban Compounded

Limited human clinical evidence

Prediction of secondary structure The engineered fusion proteins secondary structures, including the regions lacking regular shape, sections with low complexity, the proportion of random coils, extended strands, and alpha helices, were predicted by the SOPMA 64 and PORTER 65 servers

You can track this in a spreadsheet, a notes app, or a paper journal

Since Ozempic is commonly prescribed for blood sugar management, it's important to be aware of how alcohol may influence your body's glucose response

The observation of significantly lower levels of creatine in patients with Long COVID implies the potential impairment of this essential homeostatic pathway